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Abstract
Background: Canine idiopathic inflammatory bowel disease (IBD) is believed to be caused by a complex interaction of
genetic, immunologic, and microbial factors. While mucosa-associated bacteria have been implicated in the pathogenesis of
canine IBD, detailed studies investigating the enteric microbiota using deep sequencing techniques are lacking. The
objective of this study was to evaluate mucosa-adherent microbiota in the duodenum of dogs with spontaneous idiopathic
IBD using 16 S rRNA gene pyrosequencing.
Methodology/Principal Findings: Biopsy samples of small intestinal mucosa were collected endoscopically from healthy
dogs (n=6) and dogs with moderate IBD (n=7) or severe IBD (n=7) as assessed by a clinical disease activity index. Total
RNA was extracted from biopsy specimens and 454-pyrosequencing of the 16 S rRNA gene was performed on aliquots of
cDNA from each dog. Intestinal inflammation was associated with significant differences in the composition of the intestinal
microbiota when compared to healthy dogs. PCoA plots based on the unweighted UniFrac distance metric indicated
clustering of samples between healthy dogs and dogs with IBD (ANOSIM, p,0.001). Proportions of Fusobacteria (p=0.010),
Bacteroidaceae (p=0.015), Prevotellaceae (p=0.022), and Clostridiales (p=0.019) were significantly more abundant in
healthy dogs. In contrast, specific bacterial genera within Proteobacteria, including Diaphorobacter (p=0.044) and
Acinetobacter (p=0.040), were either more abundant or more frequently identified in IBD dogs.
Conclusions/Significance: In conclusion, dogs with spontaneous IBD exhibit alterations in microbial groups, which bear
resemblance to dysbiosis reported in humans with chronic intestinal inflammation. These bacterial groups may serve as
useful targets for monitoring intestinal inflammation.
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Introduction
Idiopathic inflammatory bowel disease (IBD) is a common cause
of chronic gastrointestinal disease in dogs [1]. The most common
clinical signs observed are chronic diarrhea and vomiting in
combination with histopathologic evidence of intestinal inflam-
mation [1–5]. While the exact etiology of canine IBD remains
elusive, it is suspected that, similarly to human IBD (i.e., Crohn’s
disease and ulcerative colitis), the disease process is caused by
complex interactions between environmental factors, the gastro-
intestinal microbiota, and an underlying genetic susceptibility of
the host [6–8]. Most research evidence for a causal association
between the enteric microbiota and host susceptibility as
contributors to the pathogenesis of IBD is derived from rodent
models and human IBD patients [9]. For example, in rodent
models with an underlying genetic susceptibility (i.e., IL-10 gene
deletion), intestinal inflammation develops only in the presence of
bacteria but not in germ free animals. Furthermore, recent
genome-wide association studies in humans affected by Crohn’s
Disease have revealed several susceptibility genes (e.g., NOD2/
CARD15), which are implicated in defective bacterial killing as a
consequence of impaired innate immunity [10]. Several recent
molecular studies have revealed an altered microbial composition
(i.e., dysbiosis) in the gastrointestinal tract of humans with IBD
[11,12]. The most commonly observed microbial changes are a
decrease in Firmicutes, with a predominantly reduced diversity in
Clostridium clusters XIVa and IV and a concurrent increase in the
bacterial phylum Proteobacteria in affected patients [9,11,12].
Recent studies in dogs have identified genetic factors [13,14]
and compositional changes in the duodenum of dogs with
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species richness and are significantly enriched in Proteobacteria
compared to controls [6,15]. However, these studies employed the
construction of 16 S rRNA gene clone libraries, a labor-intensive
method that typically allows only for analysis of a limited number
of 16 S rRNA gene sequences, and it is therefore likely that
changes in lower abundant microbial groups have remained
uncharacterized. New molecular tools, such as 454-pyrosequenc-
ing, allow for deeper phylogenetic coverage of the intestinal
microbiota and have demonstrated the presence of a highly
complex gastrointestinal ecosystem in healthy dogs [16–18]. The
aim of this study was, therefore, to characterize the duodenal
microbiota of dogs with chronic idiopathic IBD using a 16 S
rRNA gene pyrosequencing approach and to compare the
duodenal microbiota to that in healthy dogs. Duodenal biopsies
were selected as this part of the intestine is most commonly
affected in canine inflammatory bowel disease.
Materials and Methods
Animals and Tissue Collection
Intestinal mucosal biopsies were collected via endoscopy from
14 dogs suspected of having either moderate (n=7) or severe IBD
(n=7) based on a published clinical canine IBD activity index
(CIBDAI) [3]. The CIBDAI is based on 6 criteria, each scored on
a scale from 0–3: attitude/activity, appetite, vomiting, stool
consistency, stool frequency, and weight loss. After summation,
the total composite score is determined to be clinically insignificant
(score 0–3), mild (score 4–5), moderate (score 6–8) or severe (score
9 or greater).
Endoscopic intestinal biopsies were also collected from control
dogs (n=6), which were free from gastrointestinal signs. This study
had been approved by the Iowa State University (ISU) Institu-
tional Animal Care and Use Committee. Informed consent to
enroll clinical cases into the trial was obtained from each client.
Mucosal biopsy specimens were obtained from duodenal
mucosa by endoscopy from each dog. A subset of mucosal
specimens were placed in neutral buffered 10% formalin for H&E
microscopy while another subset of biopsies (n=4 per dog) were
immediately placed in RNA stabilization solution (RNAlater,
Qiagen) and kept at 280uC until isolation of RNA.
The control group was comprised of young adult, mixed-breed
dogs of random-source origin that were free of gastrointestinal
signs for at least six weeks prior to gastrointestinal sampling. These
dogs were acquired directly from the Iowa State University (ISU)
Laboratory Animal Resource facility as part of a pool of healthy
control animals available for use in biomedical research. All dogs
had previously been boarded for several months at local humane
shelters since being abandoned by their owners. In this previous
environment, they were housed individually, observed for clinical
signs of illness as potential adoptees, and fed a commercially
prepared adult dog maintenance diet (Teklad Laboratory Diet;
6.7 g of protein/100 kcal metabolizable energy (ME), 2.5 g of fat/
100 kcal ME, and 12.7 g of carbohydrates/100 kcal ME) (Sup-
plemental Table S1). After a several month timeline and due to
housing shortages at the shelter, the dogs were then transferred to
the ISU LAR rather than being euthanized at the shelter facility.
Each dog was again examined for illness by LAR personnel, caged
individually, and fed a commercial maintenance ration similar in
composition to the previous shelter diet. They were boarded in the
LAR area for approximately 3 months further and observed for
gastrointestinal signs prior to study enrollment. None of the dogs
were utilized as controls in other studies at ISU.
Medical records indicate that each control dog was dewormed
with fenbendazole at recommended dosages and shown to be
negative for Giardia spp. infection on repeated fecal examinations
using zinc sulfate flotation techniques and direct fecal smears. No
other medications, including antibiotics or anti-inflammatory
drugs, were administered to any control dog prior to anesthesia
for endoscopic examination. A thorough physical examination and
laboratory evaluation consisting of a CBC, biochemistry profile,
urinalysis, and GI panel at Texas A&M University (i.e., cTLI,
cPLI, folate, and cobalamin concentrations) was performed on
each dog to screen for underlying metabolic and systemic disorders
not detected on physical examination.
Sample collection of endoscopic specimens for histopathologic
analysis and RNA extraction was performed in an identical
fashion and time frame to those diagnostic procedures performed
on clinical IBD cases. A single experienced endoscopist (AEJ)
performed gastroduodenoscopy on all animals. Twelve to fifteen
small intestinal mucosal specimens were obtained from the mid to
distal duodenum using standard serrated jaw pinch forceps passed
through the 2.8 mm diameter accessory channel of the Olym-
pus
TM endoscope. The first 8–10 biopsy specimens collected on
each dog were reserved for histopathology and the next 4
specimens were harvested for molecular analysis.
Clinical cases of canine chronic enteropathy were all referral
cases into the gastroenterology service at ISU. A board-certified
internist (AEJ, Diplomate ACVIM) served as the clinician-in-
charge and oversaw the diagnostic evaluation of each dog with
assistance from the veterinary students. Over the study period, 14
consecutive dogs having moderate-to-severe clinical disease
activity were enrolled as previously described. This population of
IBD dogs represented approximately 16% of the total canine
chronic enteropathy caseload presented during the study period.
Intestinal inflammation was scored on the basis of recently
described histopathologic guidelines [19]. Mucosal biopsies from
all dogs (both control and clinical cases) were reviewed in blinded
fashion by a single experienced pathologist, board-certified by the
American College of Veterinary Pathology (ACVP). All tissues
were reviewed within 72 hours of collection and the results
reported to the gastroenterologist (AEJ).
To reach a diagnosis of idiopathic IBD, all dogs underwent
sequential therapeutic trials first with an elimination dietary trial
followed by an antibiotic trial prior to endoscopic examination. To
rule out adverse food reactions (e.g., food-responsive enteropathy)
as the cause for gastrointestinal signs, each dog was fed a restricted
antigen (i.e., novel intact protein) elimination diet for a minimal
period of three weeks. Supplementary Table S1 summarizes the
various diets the dogs received during this trial. The median (and
range) amounts of macronutrient content across all diets were: 6.8
(4.5–7.5) g of protein/100 kcal ME; 4.1 (2.9–5.0) g of fat/100 kcal
ME; 12.6 (7.9–15.0) g of carbohydrates/100 kcal ME. If the dog
failed to respond to dietary intervention alone, an antibiotic
(metronidazole, amoxicillin with clavulanic acid, or tylosin) was
administered for 14 days. If dogs failed to respond to both dietary
and antibiotic treatments, they were reevaluated to exclude other
underlying disorders causing chronic gastroenteritis. All medica-
tions including antibiotics and corticosteroids were discontinued
for at least 2 weeks prior to further diagnostic investigation. The
study internist (AEJ) judged the clinical response to sequential
treatments in each dog.
Diagnostic tests performed on IBD suspect dogs, which failed to
respond to dietary or antibiotic interventions alone, included a
CBC, serum chemistry profile, urinalysis, serum canine trypsin-
like immunoreactivity (cTLI) concentration (Canine TLI radioim-
munoassay, Siemens Medical Solutions Diagnostics), serum
Dysbiosis in Canine IBD
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Folic Acid, Siemens Medical Solutions Diagnostics), and serum C-
reactive protein concentrations (CRP; Phase
TMRange Canine C-
reactive Protein Assay, Tridelta Development Ltd). Further
diagnostic testing included evaluation of feces for nematodes and
protozoal parasites (i.e., wet mount and zinc sulfate flotation) and
survey abdominal radiographs. Some dogs also had abdominal
ultrasound performed for the evaluation of extra-alimentary tract
abnormalities, such as renal and liver disease. Control dogs were
evaluated in an identical fashion with the exception that diagnostic
imaging and determination of CRP concentration were not
performed.
454-pyrosequencing
Total RNA was extracted from the intestinal biopsies of each
dog using the RNeasy total RNA midi kit (QiagenH, Germany)
according to the protocol outlined for RNA extraction from
animal tissue. Extracted RNA was transcribed into cDNA using
random monomers and the QuantiTect Reverse Transcription Kit
with gDNA removal (Qiagen).
Bacterial tag-encoded FLX-titanium amplicon pyrosequenc-
ing (bTEFAP) based upon the V1–V3 region (E. coli position 27–
519) of the 16 S rRNA gene was performed as described
previously for canine intestinal samples at the Research and
Testing Laboratory, Lubbock, TX, USA, with primers for-
ward28F: GAGTTTGATCNTGGCTCAG and reverse519R:
GTNTTACNGCGGCKGCTG [16,18].
Raw sequence data were screened, trimmed, and filtered with
default settings using the QIIME pipeline version 1.4.0 (http://
qiime.sourceforge.net) [20]. Chimeras were detected and excluded
using the software B2C2 (http://www.researchandtesting.com/
B2C2.html) [21]. Operational taxonomic units (OTUs) were
defined as sequences with at least 97% similarity using QIIME.
For classification of sequences on a genus level the naı ¨ve Bayesian
classifier within the Ribosomal Database Project (RDP, v10.28)
was used. The confidence threshold in RDP was set to 80%.
Statistical analysis
To account for unequal sequencing depth across samples
subsequent analysis was performed on a randomly selected subset
of 840 sequences per sample. This number was chosen to avoid
exclusion of samples with lower number of sequence reads from
further analysis. Alpha diversity (i.e., rarefaction) and beta
diversity measures were calculated and plotted using QIIME.
Differences in microbial communities between disease groups were
investigated using the phylogeny-based unweighted Unifrac
distance metric. This analysis measures the phylogenetic distance
among bacterial communities in a phylogenetic tree, and thereby
provides a measure of similarity among microbial communities
present in different biological samples. To determine if any groups
of samples (either based on clinical severity or severity of
histological changes) contained significantly different bacterial
communities, the analysis of similarities (ANOSIM) function in the
statistical software package PRIMER 6 (PRIMER-E Ltd., Lutton,
UK) was used on the unweighted UniFrac distance matrix [22].
To visualize clustering of samples by their relative abundance of
bacterial families, a double dendrogram was generated using
multivariate hierarchical clustering methods in NCSS 2007
(NCSS, Kaysville, Utah) [17].
Differences in the proportions of bacterial taxa (defined as
percentage of total sequences) between healthy and IBD dogs were
determined using non-parametric Mann-Whitney U tests (Prism5,
GraphPad Software Inc.). Only taxa that were present in at least
50% of dogs (either healthy or diseased) were included in analysis.
A Fisher’s exact test was used to determine the proportions of dogs
that harbored specific bacterial taxa. The resulting P-values were
corrected for multiple comparisons on each phylogenetic level
using the Benjamini & Hochberg’s False Discovery Rate [23]. An
adjusted P,0.05 was considered for statistical significance.
Results
Disease characteristics
The base-line clinicopathologic characteristics in IBD dogs
(Table 1; Supplemental Table S1) were similar to previous reports
[3–5]. In brief, dogs were predominantly middle-aged (median age
7.5, range 3–12 years) and exhibited chronic gastrointestinal signs
of 3.6 months duration (range 1–36 months). None of the dogs had
evidence of extra-alimentary tract inflammation based on results
obtained from diagnostic testing. Seven dogs had moderate IBD
(mean CIBDAI score=6.5) and 7 dogs had severe IBD (mean
CIBDAI score=9.8). Four of 7 IBD dogs with moderate-to-severe
clinical disease were diagnosed with protein-losing enteropathy,
based on characteristic laboratory abnormalities. Endoscopic
abnormalities of the small intestines (i.e., increased friability,
granularity, and/or erosions) were observed in all IBD dogs.
Histopathologic review of biopsy specimens showed that 7 dogs
had mild, while 7 dogs had moderate-to-severe histologic lesions of
IBD (Table 1).
The mean age of the healthy control (HC) dogs was 4 years
(range 3–6 years). There were no abnormalities in the results of
physical examination, CBC, serum biochemical analysis, urinal-
ysis, multiple fecal examinations, dirofilarial antigen assay,
endoscopic examination, or histopathologic findings of mucosal
biopsies.
Microbiota in the canine duodenum
The pyrosequencing pipeline yielded 73,998 quality 16 S rRNA
gene sequences (mean 3,700 sequences per sample). A total of 9
bacterial phyla were identified across all control and IBD dogs
(Fig. 1). Proteobacteria, Bacteroidetes, Firmicutes, Actinobacteria,
and Fusobacteria represented more than 98% of all 16 S rRNA
Table 1. Baseline characteristics of study dogs.
IBD dogs (n=14) Control dogs (n=6)
Sex
male, n (%) 6 (43) 3 (50)
female, n (%) 8 (57) 3 (50)
Age
median (range), years 7.1 (3–12) 4 (3–6)
Disease duration
median (range), months 3.6 (1–36) 0
CIBDAI at endoscopy
median (range) 7 (6–12) 0
Endoscopic lesions (%) 100 0
Histopathology
normal 0 6
mild IBD 7 0
moderate-to-severe IBD 7 0
CIBDAI=canine inflammatory bowel disease activity index.
IBD=inflammatory bowel disease.
doi:10.1371/journal.pone.0039333.t001
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subset of 840 randomly selected sequences were selected to
calculate operational taxonomic units at 97% similarity (OTU97).
No significant differences in median OTU97 were observed
between disease groups: control group 112 (range 70–156); IBD
group 84 (range 54–165); p=0.4; Fig. 2)
Microbial communities in controls and dogs with IBD
Intestinal inflammation was associated with significant differ-
ences in the composition of the intestinal microbiota when
compared to healthy dogs. PCoA plots (Fig. 3) based on the
unweighted UniFrac distance metric indicated separation of
samples between healthy dogs and dogs with IBD (ANOSIM,
p,0.001), but no clustering was evident between dogs with
moderate IBD and dogs with severe IBD as assessed by the
CIBDAI (ANOSIM, p=0.14). When clustering was assessed
based on the severity of histological lesions, control dogs (normal
histology) separated significantly from all IBD dogs (Fig. 3;
ANOSIM, p,0.001). A trend was observed for separation
between dogs with mild and dogs with moderate-to-severe
histological changes (Fig. 3; ANOSIM, p=0.07). Figure 4
indicated that the clustering was predominantly due to disease
rather than to environmental factors such as gender, age, fat or
protein content in diet, and antibiotic history.
Table 2 summarizes the relative proportions of the predominant
bacterial taxa on various phylogenetic levels. Based on adjusted p-
values, Fusobacteria were significantly decreased in IBD dogs
(p=0.01), while the decrease in Firmicutes (p=0.095) and
Bacteroidetes (p=0.057), and the increase in Proteobacteria
(p=0.071) did not reach statistical significance. However,
significant differences were identified within these phyla on lower
phylogenetic levels (Table 2)
Within Proteobacteria, the major changes were observed within
the classes b- and c-Proteobacteria. The genus Diaphorobacter (class
b-Proteobacteria), a butyrate reducing bacterial group, was
significantly more frequently identified in IBD dogs (11/14 dogs)
than in controls (0/6 dogs; p=0.044). Furthermore, Burkholder-
iaceae were also significantly increased in IBD. The class c-
Proteobacteria was increased in IBD, mostly due to increases in
the order Pseudomonales and the families Moraxellaceae (genus
Acinetobacter) and Xanthomonadaceae.
Within the Firmicutes sequences belonging to Erysipelotricha-
ceae and to the Clostridiales were significantly decreased in IBD
dogs (Table 2). For the latter group the decrease was mostly due to
decreases in the families Ruminococcaceae (genus Ruminococcus),
Veillonellaceae (genus Megamonas), and Lachnospiraceae
(Table 2, Fig. 5).
Within the Bacteroidetes, the families Bacteroidaceae and
Prevotellaceae (genus Prevotella) were also significantly decreased
in dogs with IBD. No significant differences were identified for
specific bacterial genera.
Discussion
Idiopathic IBD in dogs is a commonly observed chronic
enteropathy, which remains poorly understood with regards to
disease pathogenesis. In humans, the current hypothesis for
etiopathogenesis involves genetic (i.e., NOD2 polymorphisms)
and environmental factors (e.g., enteric microbiota) which can
cause dysregulated immune responses and drive chronic intestinal
inflammation in susceptible individuals [9,24]. There is emerging
evidence that a similar etiopathogenesis also leads to chronic
enteropathies in dogs. For example, granulomatous colitis in Boxer
dogs is associated with the presence of adherent and invasive
Escherichia coli (AIEC), and these AIEC isolates share phylogenetic
and virulence similarities to AIEC isolates obtained from ileal
tissue of humans with Crohn’s disease (Simpson et al., 2006).
Polymorphisms in TLR4 and TLR5 gene receptors have been
associated with canine IBD [25]. Recent molecular studies have
revealed a bacterial [6,15] and fungal [26] dysbiosis in the
duodenum of dogs with idiopathic IBD, as these dogs showed a
significantly lower bacterial species richness (number of bacterial
taxa detected) and were significantly enriched in Proteobacteria
compared to controls. A recent study reported that German
Shepherd dogs with chronic enteropathies have an altered
expression of Toll-like receptors, which is associated with a unique
Figure 1. Average percentage of phyla identified in control dogs and dogs with IBD. Data represent the percentage of obtained total 16 S
rRNA gene sequences. Error bars represent standard deviations.
doi:10.1371/journal.pone.0039333.g001
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PLoS ONE | www.plosone.org 4 June 2012 | Volume 7 | Issue 6 | e39333Figure 2. Rarefaction analysis of 16 S rRNA gene sequences obtained from canine duodenal mucosa samples. Lines represent the
average of each group (blue=control dogs; red=dogs with idiopathic inflammatory bowel disease), while the error bars represent the standard
deviations. The analysis was performed on a randomly selected subset of 840 sequences per sample.
doi:10.1371/journal.pone.0039333.g002
Figure 3. Principal Coordinates Analysis (PCoA) of unweighted UniFrac distances of 16 S rRNA genes. The clustering indicates
differences in microbiota composition between controls and dogs with IBD. The analysis was performed on a randomly selected subset of 840
sequences per sample. Because the samples clustered along Principal Coordinates (PC) 1 and PC 2, only these graphs are shown. A – Analysis
according to clinical severity of disease based on the Canine Inflammatory Bowel Disease Activity Index (CIBDAI). Control dogs (red)
separated from dogs with idiopathic inflammatory bowel disease (IBD; blue=moderate CIBDAI; orange=severe CIBDAI) indicating differences in
microbiota ecology. No clustering is observed according to the severity of clinical disease. B – Analysis according to severity of
histopathology. Control dogs with normal histology (green) separated from dogs with idiopathic inflammatory bowel disease (IBD; blue=mild
changes on histology; orange=moderate-to-severe changes on histology). A trend was observed for separation between dogs with mild and dogs
with moderate-to-severe histological changes (ANOSIM, p=0.07).
doi:10.1371/journal.pone.0039333.g003
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sition [13].
In this study we used massive parallel pyrosequencing of the
16 S rRNA gene to evaluate potential differences in the mucosa-
adherent microbiota between dogs with idiopathic IBD and
control dogs. This automated high throughput technique allows a
more thorough, in depth characterization of the intestinal
ecosystem. Our results revealed that the canine duodenum
harbors a complex intestinal assemblage, compromising at least
9 bacterial phyla. This is in contrast to previous molecular studies
that have employed 16 S rRNA gene clone libraries and have
revealed only 7 phyla in the canine duodenum [6,27].
Our results demonstrate a dysbiosis in mucosa-adherent
microbiota between healthy control dogs and dogs with IBD.
Most notably, we observed an increase in sequences belonging to
Proteobacteria, and a decrease in bacterial groups within
Bacteroidetes, Fusobacteria, and Firmicutes. These results are in
agreement with a previous study by our group, in which we have
also observed increased proportions of sequences belonging to the
various classes of Proteobacteria in duodenal mucosal biopsies
from IBD dogs [6]. In this current study we have enrolled a new
set of control and diseased dogs (i.e., none of the dogs analyzed
here was part of the previous study), therefore confirming our
previous results. Furthermore, we have employed a deep
sequencing approach derived from RNA rather than DNA and
we have identified additional groups that are altered in the
duodenum of IBD dogs and possibly contribute to onset and
perpetuation of chronic intestinal inflammation.
Our results are also in agreement with studies in humans with
IBD, where similar patterns of dysbiosis are frequently observed.
For example, humans with Crohn’s disease consistently show a
decrease in the bacterial phyla Firmicutes and Bacteroidetes, with a
concurrent increase in Proteobacteria [12,24]. Several studies
evaluating the intestinal microbiome between controls and human
IBD patients have further shown that within the Firmicutes, the
Clostridium clusters XIVa and IV (i.e., Lachnospiraceae, Ruminococca-
ceae, Faecalibacterium prausnitzii, and C. coccoides subgroups) are
consistently decreased in Crohn’s disease patients [9,12,24]. These
bacterial groups are believed to be the major producers of short
chain fatty acids and therefore may play an important role in
intestinal health. We have identified similar changes in our study,
with decreases in Ruminococcaceae, Veillonellaceae, and Lach-
nospiraceae.
Other major phylogenetic groups that were associated with IBD
were sequences of the b-and c-Proteobacteria, which were
significantly more ubiquitous in IBD dogs, compared with
Figure 4. Principal Coordinates Analysis (PCoA) of unweighted UniFrac distances of 16 S rRNA. The analysis was performed on a
randomly selected subset of 840 sequences per sample. The PCoA plots suggest that clustering was primarily based on intestinal disease rather than
environmental factors. A – Analysis according to clinical disease. Control dogs (blue) cluster separately from dogs with IBD (red). B – Age. Blue
symbols: dogs 3–4 years of age; orange: 5–6 years; green: 7–8 years; red: 12 years.C – Gender. Red=female dogs; Blue=male dogs. D – Weeks
between last dose of antibiotic administration and sample collection. Green=6 weeks; orange=3 weeks; blue=2 weeks; red=n/a (control
dogs). E – Fat content in diet. Red=2.5–4.0 grams of fat/100 kcal ME; blue=4.1–5.0 grams of fat/100 kcal ME. F – Protein content in diet.
Red=4.0–5.9 grams of protein/100 kcal ME; blue 6.0–6.9 grams of protein/100 kcal ME; orange=7.0–7.5 grams of protein/100 kcal ME.
doi:10.1371/journal.pone.0039333.g004
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Median % of sequences No. of dogs harboring taxa
IBD * (min – max) Control (min – max) P-value
a IBD (n=14) Control (n=6) P-value
b
Phylum
Actinobacteria 1.20 (0.00–34.08) 0.79 (0.0–4.33) 0.433 13 6 1
Bacteroidetes 6.75 (1.51–26.01) 28.80 (1.64–37.04) 0.057 14 6 1
Firmicutes 4.1 (0.0–29.19) 15.29 (1.29–40.70) 0.095 12 6 1
Fusobacteria 0.00 (0.00–9.65) 14.56 (0.40–49.66) 0.010 5 6 0.07
Proteobacteria 72.54 (44.80–96.86) 31.58 (4.63–78.30) 0.071 14 6 1
Class
Alphaproteobacteria 1.91 (0.04–22.62) 0.09 (0.00–56.45) 0.353 14 4 0.14
Bacilli 0.01 (0.00–23.07) 0.00 (0.00–3.14) 0.960 7 4 0.771
Bacteroidia 0.40 (0.00–25.14) 24.70 (1.60–36.41) 0.036 8 6 0.173
Betaproteobacteria 9.87 (1.08–31.68) 1.68 (0.20–36.97) 0.408 14 6 1
Clostridia 0.04 (0.00–12.50) 12.96 (0.78–40.43) 0.024 8 6 0.197
Deltaproteobacteria 0.42 (0.00–4.82) 0.00 (0.00–0.00) 0.068 9 0 0.056
Erysipelotrichi 0.00 (0.00–5.23) 0.10 (0.00–3.59) 0.042 1 4 0.034
Flavobacteria 1.90 (0.00–9.59) 0.32 (0.00–10.18) 0.578 12 4 0.72
Fusobacteria 0.00 (0.00–9.65) 14.56 (0.40–49.66) 0.040 5 6 0.042
Gammaproteobacteria 58.42 (10.91–94.36) 4.31 (0.30–50.29) 0.018 14 6 1
Order
Actinomycetales 1.20 (0.00–34.08) 0.77 (0.00–4.32) 0.506 13 5 1
Aeromonadales 0.00 (0.00–0.00) 0.19 (0.00–3.57) 0.274 0 4 0.029
Bacteroidales 0.20 (0.00–7.17) 25.64 (2.59–38.86) 0.013 8 6 0.546
Burkholderiales 9.14 (1.08–31.68) 1.68 (0.011–36.97) 0.542 14 6 1
Caulobacterales 0.63 (0.00–22.62) 0.02 (0.00–2.49) 0.511 11 3 0.9
Clostridiales 0.00 (0.00–6.87) 12.81 (0.82–38.63) 0.019 6 6 0.265
Coriobacteriales 0.00 (0.00–0.00) 0.01 (0.00–0.25) 0.019 0 5 0.002
Enterobacteriales 8.56 (0.00–49.17) 0.23 (0.00–69.04) 0.464 13 5 0.5
Erysipelotrichales 0.00 (0.00–3.80) 0.07 (0.00–3.56) 0.295 0 4 0.029
Flavobacteriales 1.90 (0.00–9.59) 0.31 (0.00–10.18) 0.725 12 4 1
Fusobacteriales 0.00 (0.00–9.65) 14.56 (0.40–49.66) 0.010 5 6 0.33
Pseudomonadales 23.01 (0.16–91.41) 0.04 (0.00–1.48) 0.038 14 6 1
Rhizobiales 0.13 (0.00–7.75) 0.03 (0.00–9.78) 0.640 10 4 1
Sphingomonadales 0.00 (0.00–1.29) 0.04 (0.00–44.18) 0.447 5 4 0.89
Xanthomonadales 8.15 (2.32–39.12) 2.16 (0.01–7.39) 0.068 14 6 1
Family
Alcaligenaceae 0.80 (0.00–10.69) 0.57 (0.08–1.73) 0.940 13 6 1
Bacteroidaceae 0.00 (0.00–3.93) 11.09 (0.00–36.27) 0.015 3 5 0.057
Bradyrhizobiaceae 0.00 (0.00–3.42) 0.03 (0.00–8.81) 0.365 5 4 0.454
Burkholderiaceae 0.27 (0.00–7.46) 0.00 (0.00–0.03) 0.084 10 1 0.12
Caulobacteraceae 0.63 (0.00–22.62) 0.01 (0.00–2.49) 0.330 11 3 0.482
Clostridiaceae 0.00 (0.00–10.81) 7.26 (0.54–23.38) 0.069 6 6 0.184
Comamonadaceae 5.90 (0.00–30.21) 0.14 (0.00–36.44) 0.349 13 4 0.338
Coriobacteriaceae 0.00 (0.00–0.00) 0.01 (0.00–0.25) 0.015 0 4 0.022
Enterobacteriaceae 8.56 (0.00–49.17) 0.23 (0.00–69.04) 0.144 13 5 1
Erysipelotrichaceae 0.00 (0.00–5.23) 0.10 (0.00–3.59) 0.044 1 4 0.077
Flavobacteriaceae 1.90 (0.00–9.59) 0.31 (0.00–10.18) 0.587 12 4 0.699
Fusobacteriaceae 0.00 (0.00–9.65) 14.56 (0.40–49.66) 0.055 5 6 0.154
Lachnospiraceae 0.00 (0.00–0.85) 2.85 (0.00–20.72) 0.044 3 5 0.079
Moraxellaceae 7.12 (0.00–45.96) 0.00 (0.00–0.00) 0.017 13 0 0.044
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(b-Proteobacteria) was more frequently identified in dogs with
IBD. This genus contains bacterial species that are capable of
reducing poly(3-hydroxybutyrate) and poly(3-hydroxybutyrate-co-
3-hydroxyvalerate), however, the role of these compounds in
gastrointestinal health and disease and their interactions with
short-chain fatty metabolism is unknown at this point and requires
further studies [28]. This bacterial group has not yet been
associated with clinical disease in humans or animal species, and
further investigations into the potential role of this bacterial group
and its metabolic functions in the pathogenesis of canine IBD are
warranted.
Despite many studies that have identified microbial dysbiosis in
humans with gastrointestinal inflammation, the cause-effect
relationship between microbial alterations and intestinal inflam-
mation is not well understood. New hypotheses suggest that
intestinal inflammation, due to for example transient Campylobacter
jejuni or Salmonella infection, may trigger changes in mucosal
architecture and in the innate immune reactivity, which in turn
diminish the colonization resistance of the resident microbiota,
resulting in an overgrowth of pathogens [29]. Furthermore, a
depletion of commensal bacterial groups may lead to a reduced
capability of the intestinal microbiome to down-regulate an
aberrant intestinal immune response, leading to a perpetuation
of intestinal inflammation. Counterbalancing this small intestinal
dysbiosis with beneficial bacterial species (e.g. probiotics) may
therefore be a reasonable objective in the treatment of canine
inflammatory bowel disease in future studies.
A potential limitation of the present study may be the specific
selection of control dogs. Our strict study inclusion criteria (disease
free animals with normal diagnostic tests) resulted in a relatively
small population of healthy control dogs. Due to ethical concerns it
Table 2. Cont.
Median % of sequences No. of dogs harboring taxa
IBD * (min – max) Control (min – max) P-value
a IBD (n=14) Control (n=6) P-value
b
Prevotellaceae 0.00 (0.00–1.04) 3.60 (0.00–14.36) 0.022 3 5 0.066
Propionibacteriaceae 0.09 (0.00–34.08) 0.23 (0.00–1.11) 0.796 10 3 0.749
Pseudomonadaceae 20.89 (0.00–90.43) 1.01 (0.01–6.80) 0.051 13 6 1
Ruminococcaceae 0.00 (0.00–0.68) 0.46 (0.00–3.43) 0.044 2 4 0.102
Sphingomonadaceae 0.00 (0.00–1.29) 0.04 (0.00–44.18) 0.335 5 4 0.484
Succinivibrionaceae 0.00 (0.00–0.00) 0.19 (0.00–3.57) 0.045 0 4 0.068
Veillonellaceae 0.00 (0.00–0.00) 0.82 (0.00–2.84 0.004 0 4 0.033
Xanthomonadaceae 8.15 (2.32–39.12) 2.15 (0.01–7.39) 0.040 14 6 1
Genus
Achromobacter 0.53 (0.00–10.69) 0.05 (0.00–0.23) 0.138 12 4 0.699
Acinetobacter 6.65 (0.00–48.43) 0.00 (0.00–0.01) 0.040 12 1 0.079
Allobaculum 0.00 (0.00–0.00) 0.01 (0.00–1.01) 0.183 0 3 0.132
Anaerobiospirillum 0.00 (0.00–0.00) 0.02 (0.00–3.57) 0.022 0 4 0.069
Bacteroides 0.00 (0.00–3.94) 11.25 (0.00–35.89) 0.088 3 5 0.198
Brevundimonas 0.23 (0.00–22.62) 0.01 (0.00–2.49) 0.339 10 3 0.674
Chryseobacterium 0.54 (0.00–6.04) 0.23 (0.00–2.70) 0.914 9 4 1
Citrobacter 0.57 (0.00–47.7) 0.00 (0.00–0.01) 0.060 10 0 0.079
Clostridium 0.00 (0.00–10.81) 7.26 (0.54–23.38) 0.026 6 6 0.113
Delftia 0.00 (0.00–10.12) 0.00 (0.00–3.05) 0.440 8 2 0.688
Diaphorobacter 1.85 (0.00–30.79) 0.00 (0.00–0.00) 0.088 11 0 0.044
Escherichia 0.49 (0.00–37.55) 0.05 (0.00–68.91) 0.238 12 5 0.733
Faecalibacterium 0.00 (0.00–0.04) 0.02 (0.00–3.43) 0.154 1 3 0.33
Fusobacterium 0.00 (0.00–9.69) 14.51 (0.39–49.51) 0.022 5 6 0.154
Megamonas 0.00 (0.00–0.00) 0.16 (0.00–2.72) 0.044 0 3 0.096
Prevotella 0.00 (0.00–0.78) 1.11 (0.00–10.20) 0.022 0 5 0.044
Propionibacterium 0.09 (0.00–34.08) 0.23 (0.00–1.11) 0.768 10 3 0.709
Pseudomonas 20.89 (0.00–90.43) 1.01 (0.01–6.80) 0.046 13 6 1
Ruminococcus 0.00 (0.00–0.10) 0.37 (0.00–6.07) 0.029 1 4 0.102
Sphingobacterium 0.00 (0.00–15.31) 0.00 (0.00–0.00) 0.237 6 0 0.211
Sphingopyxis 0.00 (0.00–0.04) 0.04 (0.00–42.98) 0.021 1 4 0.154
Sutterella 0.00 (0.00–0.00) 0.51 (0.00–1.62) 0.018 0 4 0.081
aMann-Whitney Test;
bFisher’s exact test.
*p-values were adjusted for multiple comparisons based on the Benjamini and Hochberg False discovery rate.
doi:10.1371/journal.pone.0039333.t002
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large cohort of healthy pet dogs. While laboratory-reared, age-
matched Beagles were available for use as controls, we purposely
chose to not utilize this population since their origin, medical
histories, diet, and housing arrangements were not well charac-
terized by the vendor. Also, we could not verify conclusively
whether they had been used in other trials prior to arrival at ISU.
Furthermore, it has been suggested that research-derived Beagles
may harbor an altered intestinal microbiota and may have
evidence of intestinal disease [30]. Therefore, we chose to enroll a
smaller number of dogs of mixed-breed and of random source
origin to serve as the control group.
It is important to acknowledge that environmental factors, such
as age, dietary history and/or antibiotic history may have
potentially biased our results. Figure 4 illustrates PCoA plots of
unweighted Unifrac distances, examining the effects of these
potentially confounding factors on the duodenal microbiota of
control dogs and dogs with IBD.
There was a significant difference in age between the control
dogs and dogs with IBD (median 4 years vs. 7.5 years, respectively;
Table S1; p=0.01). However, all dogs were adults and most dogs
were considered middle-aged. Little is known about differences in
microbiota composition at the different age stages of dogs. Based
on previous culture-based results, neonatal puppies had a distinct
Figure 5. Dual hierarchal dendrogram based upon the predominant bacterial families. The clustering for bacterial families and for
individual samples from the control dogs and dogs with IBD are based upon Furthest Neighbor metric with Euclidean distances. The arrows next to
specific families denote significant differences in relative proportions observed between control and IBD dogs (based upon Mann-Whitney Test, see
Table 2). The heatmap represents the relative percentage of each family within each sample with legend presented at the top left of the figure. Of
note is that the dendrogram linkages of the bacterial families are not phylogenetic, but clustered based on relative family abundance among animals.
Thus, those samples with more similarity (less distance) are more closely related in overall bacterial diversity. Similarly, those bacterial families which
have similar percentages across all samples are more closely clustered.
doi:10.1371/journal.pone.0039333.g005
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coincided with changes in diet and physiologic processes of the
host [31]. One study compared research Beagle dogs of different
ages (less than 12 months vs. more than 11 years of age) and found
no significant differences in the cultivable bacterial groups in the
stomach and small intestine [32]. A molecular fingerprinting study
based on denaturing gradient gel electrophoresis (DGGE) showed
no significant influence of age (dogs younger than 2.5 years vs.
dogs older than 11 years) on canine fecal microbiota, although a
trend was recorded [33]. Similarly, we did not observe any trend
for clustering according to age in our study population (Fig. 4).
With the advance in high-throughput sequencing methods it will
be interesting to compare the various age groups in a larger
population of dogs to examine the effect of age on the intestinal
microbiome.
Diet is another potential confounding factor, as dogs where on
various diets (Fig. 4). There was no statistical significant difference
in protein and total carbohydrate content in the diets that were fed
to the healthy dogs (median protein content: 6.7 g/100 kcal ME;
median carbohydrate content: 12.7 g/100 kcal ME) and dogs with
IBD (median protein content: 6.8 g/100 kcal ME; median
carbohydrate content: 12.6 g/100 kcal ME 6.8 g/100 kcal ME).
However, there was a significant difference in the fat content
between groups (median fat content in the control group: 2.5 g/
100 kcal ME; median fat content in IBD group: 4.1 g/100 kcal;
p,0.001). Currently there is no consensus in veterinary literature
as what levels of fat or protein would constitute a major difference
in macronutrient content, and even less is known as what
differences in macronutrient levels would be expected to cause a
shift in the intestinal microbiome. While there is no published
consensus, the fat content in the diets fed to control dogs and also
dogs with IBD (2.5 g/100 kcal vs 4.1 g/100 kcal, respectively)
may be considered typical for standard maintenance diets (http://
vet.osu.edu/vmc/diet-manual). However, also other factors,
including the digestibility of the diets, the substrate amount and
the type entering the colon, and the type of carbohydrate present
(fibers vs. starch) could alter the populations that reside in the
gastrointestinal tract. How these factors affect the small intestinal
microbiota as evaluated here remains unknown and warrants
further studies. Based on our PCoA plots (Fig. 4) we did not
observe clear trends based on fat content or protein content.
Studies have shown that administration of antimicrobials leads
to alterations in the fecal microbiota of healthy humans [34–36].
These alterations may be noticeable already within 3–4 days of
administration, and the quickness of return to the pre-treatment
abundances of bacterial taxa is highly individualized. In some
individuals, the microbiota started to return to pre-treatment state
already within a few days after the end of administration [35], and
in most individuals the microbiota resembled the pre-treatment
state 4 weeks after the end of antibiotic administration [34].
However, some taxa failed to recover within a six month period
[34]. While these studies have examined only healthy humans,
similar results would be expected in canine fecal samples. Less is
known about the effects of antimicrobials on small intestinal
microbiota. In a previous study we have administered the
macrolide antibiotic tylosin for 14 days to healthy Beagle dogs,
and have evaluated the small intestinal microbiota before, at the
end of administration, and 14 days after the end of administration
[16]. Analysis using the Unifrac distance metric showed clustering
of samples, which were collected during tylosin administration, but
no clustering was observed 14 days after the end of antibiotic
administration. The microbial diversity and also the microbial
community resembled pre-treatment states in 3/5 dogs and 2/5
dogs, respectively. It is therefore, possible that antibiotic admin-
istration may have had an influence on the observed changes in
microbial communities in our current study, as all dogs with IBD
had a history of antibiotic administration. However, in eight of the
14 dogs with IBD the sample collection was performed more than
6 weeks after the last day of antibiotic administration, in 5 dogs
samples were collected more than 3 weeks after antibiotic
administration, and in the remaining dog the period between
antibiotic administration and sample collection was approx. 2
weeks. While previous studies have shown that the intestinal
microbiota is perturbed by antibiotic administration, it was
generally observed that the microbiota returned to pre-treatment
states within 4 weeks, although some groups were affected for
longer periods of time [16,34,35]. We performed PCoA on the
unweighted Unifrac distances to evaluate if clustering would be
associated with the time period between the last day of antibiotic
administration and sample collection (i.e., 6 weeks, 3 weeks, and 2
weeks; see Figure 4). Based on the above cited studies it would be
reasonable to assume that a potential antibiotic effect would be less
pronounced 6 weeks after cessation. Therefore, if the original
observed separation between healthy dogs and dogs with IBD was
due to an antibiotic effect rather than intestinal disease, it would be
expected that at least those dogs with IBD that have not received
antibiotics for more than 6 weeks would cluster closer to the
healthy dogs. As Figure 4 illustrates, no clustering was obvious
based on the duration of time between sample collection and
antibiotic administration. Therefore, we speculate that the
antibiotic effect is less likely to have caused the separation between
healthy dogs and dogs with IBD as observed. However, it would
be useful in future studies to compare a group of dogs with IBD to
a control group that is matched according to different pre-
treatments such as antibiotics and diet.
In future studies it will be also useful to adapt the standard
protocols for DNA extraction based on the Earth microbiome
Project (http://www.earthmicrobiome.org/emp-standard-
protocols/), to allow for better comparisons of results across
studies and laboratories. Paired samples, collected at the time of
diagnosis and post-therapy, would have been informative to see if
improvements in clinical signs are associated with changes in the
duodenal microbiota. Furthermore, it will be useful in future
studies to evaluate the role of parasites and viruses in the
etiopathogenesis of chronic inflammatory diseases in dogs.
In conclusion, results of this study indicate that a complex
mucosa-associated microbiota exists in the duodenum of dogs.
Dogs with IBD have a dysbiosis, with the observed patterns of
altered microbiota composition similar to those reported for
humans with intestinal inflammation. As in humans with IBD,
these altered bacterial groups represent potential targets for
diagnosis and the development of better treatment modalities for
canine IBD.
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